4D MOLECULAR THERAPEUTICS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for 4D MOLECULAR THERAPEUTICS IN CALL, CUSIP 35104E900.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for 4D MOLECULAR THERAPEUTICS IN CALL, CUSIP 35104E900.